DiagnaMed Holdings Introduces Cervai Brain Health AI Solution

DiagnaMed Holdings Corp announced the pilot launch of Cervai, a world-first consumer brain health and wellness AI solution that aims to 'raise a red flag' for potential brain health issues by estimating brain age and providing a brain health score.

Fabio Chianelli, chairman and CEO of DiagnaMed, commented: “After over two years in development, Cervai, a world-first consumer brain health and wellness solution that estimates brain age and provides a brain health score, is available to clinics seeking to provide a unique service that helps bridge the gaps in physical and cognitive health while enhancing client engagement and design personalized interventions in improving overall brain health."

Based on research and development at Drexel University and the University of Miami, Cervai combines a Brain Age Estimation and Brain Health Assessment tool. Cervai can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram (EEG) headset and calculating the data with a proprietary machine-learning model, as per pharmabiz.

Cervai can also determine whether a person is in the early stages of cognitive impairment or has a healthy brain. A clinically proven assessment of brain resilience, vulnerability, and performance functions is used to grade brain health. People might look for individualized diagnosis and treatments, like medication or lifestyle modifications, that could slow the onset or advancement of cognitive decline.

For the next three months, a limited 25 consumer wellness clinics in the US and Canada are eligible to participate in the Cervai Brain Health pilot program. The pilot program's ideal clinics would concentrate on mental health, physical therapy and sports, chiropractic care, clinical research for neurological and cognitive diseases, or health and wellness.